NASDAQ
3.31USD
+0.01 (+0.30%)
We have scored 12 news catalysts on Neonc Technologies Holdings, Inc. (NTHI) over the past 12 months. The biggest single-day move next to one of them came Aug 11, 2026, when NTHI closed +24.3%: “NTHI Brain Cancer Phase 2 Data Expected to Spark Triple Confluence”. Coverage across the window leans positive (average ticker sentiment +0.69). Most of the impact sits in price momentum and short squeeze potential.
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
85.8M
P/E
—
EPS
—
Beta
0.50
52W range
2.955-12.99
Day range
3.27–3.52
Open
3.36
Prev close
3.30
Volume
130.3K
Avg volume
154.2K
Dividend
0.00
IPO
2025-03-26
Daily OHLCV with SMA overlays and session pivots. Draw your levels and trendlines on it, or ask the AI analyst what the price is reacting to.
Suppliers, customers, partners and competitors, derived from what the news actually says about Neonc Technologies Holdings, Inc. — not a sector bucket. Click an edge to see the articles that established the link.
Latest scored catalyst for NTHI: .
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
NeOnc Technologies Holdings, Inc. is a clinical-stage biopharmaceutical company. It develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company was founded in 2008 and is headquartered in Calabasas, CA.
